Parole chiave di "Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab"

Label

• Parole chiave di "Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab" (literal)
• Keywords of "Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab" (literal)

Insieme di parole chiave di

• Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Ha membro

• first-line chemotherapy (Parola chiave)
• angiogenesis (Parola chiave)
• bevacizumab (Parola chiave)
• paclitaxel (Parola chiave)
• single nucleotide polymorphisms (Parola chiave)
• advanced breast cancer (Parola chiave)
• pharmacogenetics (Parola chiave)
• multifactor dimensionality reduction methodology (Parola chiave)

Incoming links:

Insieme di parole chiave

• Pharmacogenetic interaction analysis of VEGFR-2 and IL-8 polymorphisms in advanced breast cancer patients treated with paclitaxel and bevacizumab (Articolo in rivista) (http://www.cnr.it/ontology/cnr/individuo/prodotto/TIPO1101)

Membro di

• angiogenesis (Parola chiave)
• paclitaxel (Parola chiave)
• pharmacogenetics (Parola chiave)
• advanced breast cancer (Parola chiave)
• bevacizumab (Parola chiave)
• first-line chemotherapy (Parola chiave)
• single nucleotide polymorphisms (Parola chiave)
• multifactor dimensionality reduction methodology (Parola chiave)